REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Inmunologico Santa Rita S A S (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores
Full name: Centro Inmunologico Santa Rita S A S Profile Updated: July 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Centro Inmunologico Santa Rita S A S is a company based in Colombia, with its head office in Zipaquira. It operates in the Other Ambulatory Health Care Services industry. Centro Inmunologico Santa Rita S A S was incorporated on May 04, 2016. The company’s latest financial report indicates a net sales revenue increase of 8.04% in 2024. There was a total negative growth of 26.95% in Centro Inmunologico Santa Rita S A S’s total assets over the same period. The net profit margin of Centro Inmunologico Santa Rita S A S decreased by 13.58% in 2024.

Headquarters
Cr 15 No. 1 40 Lc 101
Zipaquira; Cundinamarca;

Contact Details: Purchase the Centro Inmunologico Santa Rita S A S report to view the information.

Basic Information
Registered Capital:
Purchase the Centro Inmunologico Santa Rita S A S report to view the information.
Financial Auditors:
Purchase the Centro Inmunologico Santa Rita S A S report to view the information.
Incorporation Date:
May 04, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Inmunologico Santa Rita S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.04%
Total operating revenue
8.04%
Operating profit (EBIT)
-83.54%
EBITDA
-83.54%
Net Profit (Loss) for the Period
-87.2%
Total Assets
-26.95%
Total Equity
-13.12%
Operating Profit Margin (ROS)
-21.98%
Net Profit Margin
-13.58%
Return on Equity (ROE)
-51.5%
Quick Ratio
-0.18%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?